Orphan Drugs Market 2022: Global Size, Trends, Potential Growth and Key Factors

Posted by Ankit Dwivedi on March 10th, 2022

As per Fortune Business Insights, the North America “Orphan Drugs Market” was worth US$ 67,136.0 Mn in 2017 and will continue to rise at a steady pace until 2025. This is mainly ascribable to the rising awareness among people regarding the use of novel drugs. In addition to this, North America is expected to offer attractive growth opportunities on the back of recent FDA approvals on the development of orphan drugs. Governments in North America are increasingly spending on research and development (R&D) of orphan drugs and technologies. According to the report, the global orphan drugs market was valued at US$ 125000 Mn in 2017 and is anticipated to reach US$ 294000 Mn by 2025. The report also stated that the market would exhibit a remarkable CAGR of 11.4% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/orphan-drugs-market-100088

Leading Players operating in the Orphan Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Bayer AG
• Hoffmann-La Roche Ltd.
• Alexion Pharmaceuticals Inc.
• Novo Nordisk A/S
• Novartis AG
• Bristol-Myers Squibb Company
• AstraZeneca Plc.
• Daiichi Sankyo Company Limited
• GlaxoSmithKline Plc.
• Amgen Inc.

Detailed Table of Content:

• Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
• Executive Summary
• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Market Trends
• Key Insights
  • Prevalence of major orphan disease, by key countries
  • Pipeline review for orphan drugs
  • Technological Developments
  • Healthcare spending for key countries – 2017
• Global Orphan Drugs Market Analysis, Insights and Forecast, 2014-2025
  • Key Findings / Summary
  • Market Analysis, Insights and Forecast – By Therapy Area
    • Oncology
    • Hematology
  • 2.3 Neurology
    • Endocrinology
    • Cardiovascular
    • Respiratory
    • Immunotherapy
    • Others
  • Market Analysis, Insights and Forecast – By Drug Type
    • Biologics
    • Non-Biologics
  • Market Analysis, Insights and Forecast – By Distribution Channels
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Sales
    • Others
  • Market Analysis, Insights and Forecast – By Geography
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

TOC Continued…